You have 9 free searches left this month | for more free features.

MALT

Showing 26 - 50 of 183

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Carcinoma, Hepatocellular, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Seoul (Microwave ablation)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • +3 more
  • Microwave ablation
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 23, 2023

ICU Delirium Trial (Beer)

Recruiting
  • ICU Delirium
  • Beer
  • Water
  • Basel, Switzerland
    University Hospital Basel
Jan 31, 2023

Helicobacter Pylori Infection in Patients With Chronic Tonsillits Trial in Sohag (Rapid urease test for h pylori)

Recruiting
  • Helicobacter Pylori Infection in Patients With Chronic Tonsillits
  • Rapid urease test for h pylori
  • Sohag, Egypt
    Sohag university Hospital
Oct 31, 2023

Non-Hodgkin's Lymphoma (NHL), Activated B-Cell Type DLBCL (ABC-DLBCL), Mantle Cell Lymphoma (MCL) Trial in Indianapolis, Spokane

Recruiting
  • Non-Hodgkin's Lymphoma (NHL)
  • +4 more
  • Indianapolis, Indiana
  • +1 more
Jul 12, 2022

Lymphoma Trial in Orlando, Houston (Amoxicillin, Bismuth Subsalicylate, Clarithromycin)

Completed
  • Lymphoma
  • Orlando, Florida
  • +1 more
Oct 23, 2018

B-cell Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia Trial in France, United States (XmAb13676)

Recruiting
  • B-cell Non-Hodgkins Lymphoma
  • Chronic Lymphocytic Leukemia
  • XmAb13676
  • La Jolla, California
  • +21 more
Oct 20, 2021

Takecab for "Supplement to Helicobacter Pylori Eradication"

Completed
  • Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other
  • Tokyo, Japan
    Takeda Selected Site
Dec 25, 2018

Helicobacter Pylori Infection Trial in Changsha (Saccharomyces Boulardii 250 MG, Ilaprazole.Doxycycline. Furazolidone. Colloidal

Recruiting
  • Helicobacter Pylori Infection
  • Saccharomyces Boulardii 250 MG
  • Ilaprazole.Doxycycline. Furazolidone. Colloidal Bismuth Tartrate
  • Changsha, Hunan, China
    The Third Xiangya Hospital of Central South University
Jan 11, 2022

Non-Hodgkin Lymphoma Trial in Switzerland (Copanlisib, Venetoclax)

Terminated
  • Non-Hodgkin Lymphoma
  • Basel, Switzerland
  • +5 more
Mar 18, 2022

Underage Drinking, Alcohol Use, Underage Trial in Clifton (Parenting Now, Active Control Materials)

Completed
  • Underage Drinking
  • Alcohol Use, Underage
  • Parenting Now
  • Active Control Materials
  • Clifton, New Jersey
    REAL Prevention, LLC
Sep 15, 2022

MALT Trial in Worldwide (chlorambucil (drug), rituximab+chlorambucil, rituximab)

Completed
  • Lymphoma, Mucosa-Associated Lymphoid Tissue
  • chlorambucil (drug)
  • +2 more
  • Antwerpen, Belgium
  • +74 more
Mar 1, 2019

Consequences of Obstetric Anal Sphincter Injuries on Maternal

Not yet recruiting
  • Obstetric Complication
  • +6 more
    • London, Brent, United Kingdom
      London Northwest Healthcare NHS Trust
    Jun 28, 2023

    Biological Insights of First Relapsed-refractory Mantle Cell

    Not yet recruiting
    • Mantle Cell Lymphoma
      • Milano, MI, Italy
      • +29 more
      Nov 11, 2021

      Marginal Zone Lymphoma Trial in Germany (Obinutuzumab)

      Active, not recruiting
      • Marginal Zone Lymphoma
      • Bochum, Germany
      • +15 more
      Nov 4, 2022

      Alcoholic Liver Disease, Liver Cirrhosis, Alcoholic, Probiotics Trial in Odense (Profermin Plus, FSMP, probiotics, Fresubin,

      Active, not recruiting
      • Alcoholic Liver Disease
      • +3 more
      • Profermin Plus, FSMP, probiotics
      • Fresubin, dietary supplement
      • Odense, Fyn, Denmark
      • +1 more
      Aug 18, 2022

      Growth Disorders Trial

      Not yet recruiting
      • Growth Disorders
        • (no location specified)
        Sep 15, 2021

        IgA Nephropathy at High Risk of Developing ESRD Trial in Beijing (The Yi-Qi-Qing-Jie herbal compound, Immunosuppressants,

        Recruiting
        • IgA Nephropathy at High Risk of Developing ESRD
        • The Yi-Qi-Qing-Jie herbal compound
        • +3 more
        • Beijing, Beijing, China
          Guang anmen Hospital, China Academy of Chinese Medical Sciences
        Mar 15, 2022

        Sjogren's Syndrome, Autoimmune Diseases Trial in Hangzhou (Assigned Interventions CD19/BCMA CAR T-cells)

        Recruiting
        • Sjogren's Syndrome
        • Autoimmune Diseases
        • Assigned Interventions CD19/BCMA CAR T-cells
        • Hangzhou, Zhejiang, China
          The First Affiliated Hospital, College of Medicine, Zhejiang Uni
        Oct 11, 2021

        Microbiota, Overweight and Obesity, Metabolic Complication Trial in Bari (Placebo, SuperFood)

        Completed
        • Microbiota
        • +2 more
        • Placebo
        • SuperFood
        • Bari, BA, Italy
          Department of Biomedical Sciences and Human Oncology - Clinica m
        Jul 6, 2022

        Underage Drinking, Driving Under the Influence, Drinking, Teen Trial in University Park (P-Chat, PBI, P-Chat+)

        Recruiting
        • Underage Drinking
        • +3 more
        • P-Chat
        • +2 more
        • University Park, Pennsylvania
          Penn State University
        Oct 7, 2022

        Marginal Zone Lymphoma Trial in Austria, Germany (Copanlisib, Rituximab)

        Recruiting
        • Marginal Zone Lymphoma
        • Wien, Austria
        • +19 more
        Mar 14, 2022

        Mental Illness Trial in Jessheim, Lillestrøm (Medication free treatment, Treatment as usual Myrvegen, Treatment as usual Åråsen)

        Active, not recruiting
        • Mental Illness
        • Medication free treatment
        • +2 more
        • Jessheim, Norway
        • +1 more
        Aug 26, 2022